Are Mirafast (polyethylene glycol 3350 with electrolytes) and MiraLAX (polyethylene glycol 3350) the same medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, Mirafast and MiraLAX are NOT the same drug

MiraLAX contains polyethylene glycol 3350 (PEG 3350) WITHOUT electrolytes, while products containing PEG 3350 WITH electrolytes (such as those used for bowel preparation) are different formulations. If "Mirafast" refers to a PEG formulation with electrolytes, these are distinct medications with different compositions, indications, and dosing regimens 1, 2.

Key Distinctions Between PEG Formulations

MiraLAX (PEG 3350 alone)

  • Composition: Polyethylene glycol 3350 without electrolytes 2
  • Standard dose: 17 g once daily mixed in 8 ounces of liquid 1
  • FDA indication: Treatment of occasional constipation 1
  • Clinical use: Chronic idiopathic constipation for up to 6-12 months 1, 3

PEG 3350 with Electrolytes

  • Composition: PEG 3350 plus electrolytes (sodium, potassium, chloride) 1, 4
  • Typical dosing: 13.7-17.5 g twice daily in studies 1, 4
  • Primary use: Often used for bowel preparation or in specific constipation protocols 4, 5

Clinical Implications

The presence or absence of electrolytes matters clinically:

  • Electrolyte balance: PEG with electrolytes is designed to prevent electrolyte disturbances during higher-volume or more intensive use 4, 5
  • Dosing frequency: Studies using PEG with electrolytes often employed twice-daily dosing, while PEG 3350 alone (MiraLAX) is typically once daily 1
  • Efficacy: Both formulations demonstrate effectiveness for constipation, but they were studied under different protocols 1, 4, 5

Common Pitfall to Avoid

Do not assume all PEG products are interchangeable. While both formulations work as osmotic laxatives through the same mechanism, the electrolyte content affects:

  • Appropriate patient selection (those with renal insufficiency or electrolyte disorders may require specific formulations)
  • Dosing schedules
  • Volume of fluid required for administration
  • Potential for electrolyte disturbances with prolonged use

If prescribing or recommending a PEG product, verify the specific formulation (with or without electrolytes) and ensure the dosing matches the product type 1, 2, 4.

Related Questions

Is it safe to administer polyethylene glycol 3350 (MiraLAX) to a patient with hypermagnesemia, hyperphosphatemia, hypercalcemia, and hypokalemia?
Can polyethylene glycol 3350 (Miralax) be administered to a 3‑year‑old child?
What are the benefits and risks of taking polyethylene glycol 3350 (Miralax) daily?
Can a patient with a colostomy bag safely take MiraLAX (polyethylene glycol 3350) to treat a colonic stool burden identified on computed tomography?
For a 72‑year‑old man with mild frequent constipation, which is the better strategy for regularity and overall health: a daily 17 g dose of polyethylene glycol 3350 (PEG 3350) or daily 2/3 cup General Mills Fiber One cereal with 2/3 cup low‑fat milk, considering weight, nutrition, glycemic control (A1C) and gut microbiome health?
Is a baseline sleep study (overnight polysomnography) warranted in a patient with a BMI of 38.3 who is on long‑term intramuscular testosterone and has a hematocrit of 48.6%?
When should booster vaccinations be administered following splenectomy?
What are alternative treatments to midodrine for managing symptomatic hypotension?
What are the treatment options for a refractory venous shin ulcer?
Please simplify the echocardiogram findings: normal‑sized left ventricle with mildly reduced systolic function (ejection fraction 40‑45 %), inferior and inferolateral wall hypokinesis, moderate concentric left ventricular hypertrophy, grade I diastolic dysfunction (impaired relaxation), normal‑sized right ventricle with normal systolic function, moderately thickened mitral valve leaflets with mild mitral stenosis.
Which medications are approved for treating bipolar disorder in a breastfeeding mother?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.